Cite
HARVARD Citation
Kenet, G. et al. (2017). Estimating the potential cost of a high dose immune tolerance induction (ITI) therapy relative to the cost of a combined therapy of a low dose ITI therapy with bypassing agent prophylaxis. Haemophilia. 23 (5), pp. e394-e402. [Online].